We hope you will join us next year for the Eleventh Annual Drug Discovery Chemistry, which will take place at the Hilton San Diego Resort & Spa from April 19-22, 2016. New for 2016 will be the addition of three symposia on Friday covering the blood-brain barrier, biophysical approaches for drug discovery, and antivirals. For suggestions on program topics or speakers, please contact Dr. Anjani Shah.
More than 500 participants from 30 countries gathered in beautiful San Diego for Cambridge Healthtech Institute’s Tenth Annual Drug Discovery Chemistry conference. Focused on discovery and optimization challenges of small molecule drug candidates, this event once again provided many exciting opportunities for scientists to create a unique program according to personal interests by encouraging track-hopping between multiple synergistic conference tracks. 25% of attendees were from the pharmaceutical industry with an additional 40% from biotech and 22% from academia. 24% were titled as executive/director, 42% as scientist/technologist, and 13% as professor.
The 2015 event was highlighted by two plenary keynote presentations:
On Day 1, Dr. Brian Shoichet, Professor of Pharmaceutical Chemistry at the University of California, San Francisco, discussed chemotype representation on inhibitor discovery, fragment-based screens, whole organism phenotypic screens, and screens to deorphanize enzymes and GPCRs.
On Day 3, Dr. Harren Jhoti, President & CEO of Astex Pharmaceuticals, spoke on how fragment-based drug discovery has evolved over the last 15 years and challenged the conventional thinking in drug discovery.
Breakout discussions were once again incredibly popular as attendees took advantage of 18 opportunities to network, collaborate and problem solve with experts in particular research areas. Participants were excited to meet potential collaborators, share examples from their work, vet ideas with peers, and be part of group problem-solving endeavors.
In addition to record attendance, this year’s event also featured more than 60 posters on display in the exhibit area, and a new poster competition for academic submissions. The two grad student/post-doc winners of the cash prizes were: Mark Johnson, Medical University of South Carolina: ...Epigenetic Modulators for Use in Cancer and Cardiovascular Diseases and Rebecca Horbert, Christian Albrechts University: Photoactivatable Prodrugs of Anti-Melanoma Agent Vemurafenib.
Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program by going back and forth between concurrent meeting tracks to hear presentations most suited to one's personal interests.
The 2015 event will feature:
Sponsorship & Exhibit Opportunities
Participating as a sponsor or exhibitor provides
excellent exposure and networking with more
than 500 high-level decision makers!
Chemotype Coverage in Fragment, Phenotypic, & Deorphanization Screens
Brian K. Shoichet, Ph.D., Professor, Department of Pharmaceutical Chemistry, University of California, San Francisco
Fragment-Based Drug Discovery: A Fifteen Year (Re-)Evolution
Harren Jhoti, Ph.D., President & CEO, Astex Pharmaceuticals
Make the most of your time in San Diego by adding on one or more short courses*. Topics include trends in physical properties, GPCRs, molecular interactions, designing peptide therapeutics, immunology, macrocycles, fragment-based design, and targeted covalent inhibitors. * separate registration required for short courses